Be Safe works with children and young people who have engaged in problematic sexual behaviour (PSB) or harmful sexual behaviour (HSB), their parents/carers and those supporting them. Click here for more information.
Children and young people who display harmful sexual behaviour often need help and may have experienced harm themselves. Be Safe is part of Specialist CAMHS (Child and Adolescent Mental Health Service), and offers direct assessment and therapeutic intervention (‘treatment’) services to children, young people and their families, as well as advice, training and consultation to a broad range of professionals.
The Avon and Wiltshire Mental Health Partnership NHS Trust (AWP) website provides full details of the service offered and contains up to date leaflets, referral forms and other documents
For the child or young person to access services:
The service encourages referrers to discuss their concerns with Be Safe before completing the referral form. Please contact the Be Safe team on: 0117 3408700 or via the team’s email on: awp.besafe@nhs.net. The referral form is available on the AWP website: Be Safe service :: Avon and Wiltshire Mental Health Partnership NHS Trust (awp.nhs.uk)
YISP covers children aged 10-17 with a wide range of harmful behaviours including harmful sexual behaviours, low school attendance, weapons education and relationship difficulties.
Please see the link for more information on the service and how to refer: Youth Inclusion Support Project (YISP) | North Somerset Council
For both services a child or young person can be referred by any professional working with them, but consent is needed from the child/young person’s parent/carer and child/ young person if they have the capacity to understand and agree.
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.